Invention Grant
- Patent Title: Anti-TNF alpha antibody formulations
-
Application No.: US17820958Application Date: 2022-08-19
-
Publication No.: US12247071B2Publication Date: 2025-03-11
- Inventor: William J. Callahan , Rahul Rajan Kaushik , Joy Brennan
- Applicant: Amgen Inc.
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen Inc.
- Current Assignee: Amgen Inc.
- Current Assignee Address: US CA Thousand Oaks
- Agent Carlos Garcia
- Main IPC: C07K16/24
- IPC: C07K16/24 ; A61K9/00 ; A61K9/08 ; A61K47/10 ; A61K47/18
Abstract:
Stable adalimumab formulations are disclosed.
Public/Granted literature
- US20230151086A1 ANTI-TNF ALPHA ANTIBODY FORMULATIONS Public/Granted day:2023-05-18
Information query
